Skip to content

INTRAFIX 254829Recalls & reported problems

Medos International Sàrl · INTRAFIX Advance Large Trial 25-40mm Plus or Minus 1 Percent · Class 1

All models of INTRAFIX (32)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10886705026326), received between Dec 19, 2018 and May 9, 2022 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Detachment of Device or Device Component1
  • Device Contaminated During Manufacture or Shipping1
  • Device Contamination with Chemical or Other Material1

Patient problems

  • No Consequences Or Impact To Patient2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 9, 2022Detachment of Device or Device Component; Detachment of Device or Device Component

    IT WAS REPORTED BY THE SALES REP THAT DURING AN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION ON (B)(6) 2022, IT WAS OBSERVED THAT THE PURPLE PORTION ON THE INTRFX ADV - LG TRIAL/DILATOR DEVICE FELL OUT. ANOTHER LIKE DEVICE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT CONSEQUENCES NOR SURGICAL DELAY REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14337548 ↗
  • MalfunctionJun 18, 2020Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping

    IT WAS REPORTED BY THE SALES REP VIA PHONE THAT DURING AN ACL PROCEDURE THE INTRAFIX ADVANCE LARGE TRIAL HAD BONE RESIDUE IN THE CANAL OF THE DEVICE AND COULD NOT BE USED ANYMORE. ANOTHER DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT CONSEQUENCES OR SURGICAL DELAY REPORTED. THE DEVICE IS AVAILABLE FOR EVALUATION.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10172034 ↗
  • MalfunctionDec 19, 2018Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material

    THIS IS REPORT 2 OF 9 FOR THE SAME EVENT. IT WAS REPORTED BY THE SALES REP THAT PRIOR TO AN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION PROCEDURE DURING STERILIZATION, THE SALES REP'S INTRAFIX SMALL TRIAL, INTRAFIX LARGE TRIAL, INTRAFIX EXTRA LARGE TRIAL, INTRAFIX SMALL 23MM SHEATH INSERTER, INTRAFIX LARGE 23MM SHEATH INSERTER, INTRAFIX SMALL 30MM SHEATH INSERTER, INTRAFIX LARGE 30MM SHEATH INSERTER, INTRAFIX EXTRA LARGE 30MM SHEATH INSERTER, AND INTRAFIX HEX DRIVER ALL HAD BLOOD RESIDUE IN THE CANNULATED PORTIONS OF THE DEVICES. THE SALES REP STATED THAT THE FACILITY ATTEMPTED TO STERILIZE THE DEVICES THREE TIMES AND THE DEVICES COULD NOT BE CLEANED. THE CASE WAS COMPLETED WITH ANOTHER SET WITH NO PATIENT HARM OR DELAY. THE SALES REP COULD NOT PROVIDE LOT NUMBERS FOR THE DEVICES. THE DEVICES ARE BEING RETURNED FOR EVALUATION. THERE WAS PATIENT INVOLVEMENT REPORTED. THERE WERE NO INJURIES, MEDICAL INTERVENTION OR PROLONGED HOSPITALIZATION. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. IF ADDITIONAL INFORMATION SHOULD BECOME AVAILABLE, A SUPPLEMENTAL MEDWATCH REPORT WILL BE SUBMITTED ACCORDINGLY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8182075 ↗

Other ORTHOPEDIC MANUAL SURGICAL INSTRUMENT devices

All ORTHOPEDIC MANUAL SURGICAL INSTRUMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page